KATINKO INHALER
Natural health product licensed in Canada
- Licence holder
- Greenstone Pharmaceutical, Inc.
- NPN or DIN-HM
- 80145115
- Status
- Active licence
- Licence date
- 3 November 2025
- Revision date
- Not provided
- Form
- Vapeur provenant d'un liquide
- Route of administration
- Inhalation
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| l-Menthol Source : l-Menthol | 7 % |
Non-medicinal ingredients
Huile de Lavandula Angustifolia (lavande), Huile de feuilles d'Eucalyptus globulus
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants, adolescents et adultes | minimum: 2 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Provides soothing vapours that) Help(s) (to) temporarily relieve mild nasal congestion and cough associated with the common cold.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80145115
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.